Armon Sharei
Founder and CEO, Portal Biotechnologies
Armon Sharei is listed as Founder and CEO, Portal Biotechnologies. Armon is scheduled to speak at SLAS 2027 International Conference & Exhibition on 3 February 2027.
Compiled from published conference agendas; not yet confirmed by Armon. Is this you? Claim this profile.
About
Armon Sharei, PhD, is the founder of Portal Biotechnologies. He was previously Founder and CEO of SQZ Biotechnologies (NYSE: SQZ), a clinical-stage cell therapy company. During his tenure, SQZ raised over $300M in equity, established a >$1B collaboration with Roche, advanced three oncology clinical trials, and completed an IPO. Dr. Sharei received his PhD in Chemical Engineering from MIT and conducted postdoctoral research in Immunology at Harvard. In addition to over 40 publications and patents, his work has been recognized as one of Scientific American’s Top 10 World-Changing Ideas and a World Economic Forum Technology Pioneer.